Cargando…
Probiotics in Cancer
In recent years, the consumption of over-the-counter probiotics to promote health has grown rapidly worldwide and become an independent industry. In medicine, various studies have demonstrated that probiotics can help improve the immune system and intestinal health. They are usually safe, but in som...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006328/ https://www.ncbi.nlm.nih.gov/pubmed/33791223 http://dx.doi.org/10.3389/fonc.2021.638148 |
_version_ | 1783672292927078400 |
---|---|
author | Lu, Ke Dong, Shanwu Wu, Xiaoyan Jin, Runming Chen, Hongbo |
author_facet | Lu, Ke Dong, Shanwu Wu, Xiaoyan Jin, Runming Chen, Hongbo |
author_sort | Lu, Ke |
collection | PubMed |
description | In recent years, the consumption of over-the-counter probiotics to promote health has grown rapidly worldwide and become an independent industry. In medicine, various studies have demonstrated that probiotics can help improve the immune system and intestinal health. They are usually safe, but in some rare cases, they may cause concerning adverse reactions. Although the use of probiotics has been widely popularized in the public, the results of many probiotic clinical trials are contradictory. Particularly in cancer patients, the feasibility of probiotic management providing benefits by targeting cancer and lessening anticancer side effects requires further investigation. This review summarizes the interactions between probiotics and the host as well as current knowledge on the pros and cons of utilizing probiotics in cancer patients. |
format | Online Article Text |
id | pubmed-8006328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80063282021-03-30 Probiotics in Cancer Lu, Ke Dong, Shanwu Wu, Xiaoyan Jin, Runming Chen, Hongbo Front Oncol Oncology In recent years, the consumption of over-the-counter probiotics to promote health has grown rapidly worldwide and become an independent industry. In medicine, various studies have demonstrated that probiotics can help improve the immune system and intestinal health. They are usually safe, but in some rare cases, they may cause concerning adverse reactions. Although the use of probiotics has been widely popularized in the public, the results of many probiotic clinical trials are contradictory. Particularly in cancer patients, the feasibility of probiotic management providing benefits by targeting cancer and lessening anticancer side effects requires further investigation. This review summarizes the interactions between probiotics and the host as well as current knowledge on the pros and cons of utilizing probiotics in cancer patients. Frontiers Media S.A. 2021-03-12 /pmc/articles/PMC8006328/ /pubmed/33791223 http://dx.doi.org/10.3389/fonc.2021.638148 Text en Copyright © 2021 Lu, Dong, Wu, Jin and Chen http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Lu, Ke Dong, Shanwu Wu, Xiaoyan Jin, Runming Chen, Hongbo Probiotics in Cancer |
title | Probiotics in Cancer |
title_full | Probiotics in Cancer |
title_fullStr | Probiotics in Cancer |
title_full_unstemmed | Probiotics in Cancer |
title_short | Probiotics in Cancer |
title_sort | probiotics in cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006328/ https://www.ncbi.nlm.nih.gov/pubmed/33791223 http://dx.doi.org/10.3389/fonc.2021.638148 |
work_keys_str_mv | AT luke probioticsincancer AT dongshanwu probioticsincancer AT wuxiaoyan probioticsincancer AT jinrunming probioticsincancer AT chenhongbo probioticsincancer |